News tagged with phase iii
Related topics: patients , clinical trials
Large clinical trial finds pirfenidone may help lung function in IPF patients
A large, well-controlled, multi-national clinical trial program has demonstrated the effectiveness and safety of what may become the first FDA-approved medicine for idiopathic pulmonary fibrosis, or IPF.
May 17, 2009 |
5 / 5 (1) |
0
